News 
Market Data 
Discover
Replies to post #8239 on SiNtx Technologies Inc (SINT)
Stock price and current revenues a smokescreen to value:
They distract from the value of the technology . Current sales are not more than test marketing and proving the quality of amda product -- the product data is a useful building block, and is what is valuable from this activity, but not the actual sales revenue figures. Especially considering the PEEK boys have tried to slow amda sales down making sales numbers even more irrelevant ...Anyways, that is likely to be expected..
Lets look at the dental implant segment -- about $5 Billion. This segment may be easier to ramp up since outside of traditional hospitals, and a market that focuses on the strength/weight characteristics as well as anti microbial qualities.... Seems like a pretty attractive segment well suited to advanced SiNi.. If amda could get just 20% of this segment, this would justify approximately a $2 Billion dollar market cap (value) alone.. and remember thats a very small slice out of the overall implant market of $125 Billion.... The shocker is that AMDA second gen SiNi tech should be able to dominate with good management in this much larger market...
The value is all the in the tech..... current stock price and current rev numbers are a side show..
Stock price and current revenues a smokescreen to value:
They distract from the value of the technology . Current sales are not more than test marketing and proving the quality of amda product -- the product data is a useful building block, and is what is valuable from this activity, but not the actual sales revenue figures. Especially considering the PEEK boys have tried to slow amda sales down making sales numbers even more irrelevant ...Anyways, that is likely to be expected..
Lets look at the dental implant segment -- about $5 Billion. This segment may be easier to ramp up since outside of traditional hospitals, and a market that focuses on the strength/weight characteristics as well as anti microbial qualities.... Seems like a pretty attractive segment well suited to advanced SiNi.. If amda could get just 20% of this segment, this would justify approximately a $2 Billion dollar market cap (value) alone.. and remember thats a very small slice out of the overall implant market of $125 Billion.... The shocker is that AMDA second gen SiNi tech should be able to dominate with good management in this much larger market...
The value is all the in the tech..... current stock price and current rev numbers are a side show...
Stock price and current revenues a smokescreen to value:
They distract from the value of the technology . Current sales are not more than test marketing and proving the quality of amda product -- the product data is a useful building block, and is what is valuable from this activity, but not the actual sales revenue figures. Especially considering the PEEK boys have tried to slow amda sales down making sales numbers even more irrelevant ...Anyways, that is likely to be expected..
Lets look at the dental implant segment -- about $5 Billion. This segment may be easier to ramp up since outside of traditional hospitals, and a market that focuses on the strength/weight characteristics as well as anti microbial qualities.... Seems like a pretty attractive segment well suited to advanced SiNi.. If amda could get just 20% of this segment, this would justify approximately a $2 Billion dollar market cap (value) alone.. and remember thats a very small slice out of the overall implant market of $125 Billion.... The shocker is that AMDA second gen SiNi tech should be able to dominate with good management in this much larger market...
The value is all the in the tech..... current stock price and current rev numbers are a side show...
AI
